Literature DB >> 2670584

Resistance to platinum compounds: mechanisms and beyond.

S L Kelley1, M Rozencweig.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2670584     DOI： 10.1016/0277-5379(89)90405-7

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN： 0277-5379


× No keyword cloud information.
  9 in total

1.  Cisplatin but not BCNU inhibits urokinase-type plasminogen activator levels in human glioblastoma cell lines in vitro.

Authors:  Y Go; S K Chintala; A Rayford; E Gagercas; F Ali-Osman; B Venkaiah; R Sawaya; Z Gokaslan; G L Nicolson; J S Rao
Journal:  Clin Exp Metastasis       Date:  1997-07       Impact factor: 5.150

2.  Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.

Authors:  Kalpana Mujoo; Masayuki Watanabe; Junichi Nakamura; Abdul R Khokhar; Zahid H Siddik
Journal:  J Cancer Res Clin Oncol       Date:  2003-09-26       Impact factor: 4.553

Review 3.  Cellular accumulation of the anticancer agent cisplatin: a review.

Authors:  D P Gately; S B Howell
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

4.  Cytotoxicity of cis-[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(myristato)]-platinum (II) suspended in Lipiodol in a newly established cisplatin-resistant rat hepatoma cell line.

Authors:  S Kishimoto; K Miyazawa; Y Terakawa; H Ashikari; A Ohtani; S Fukushima; Y Takeuchi
Journal:  Jpn J Cancer Res       Date:  2000-12

5.  In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.

Authors:  K J Mellish; L R Kelland; K R Harrap
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

Review 6.  Modulation of cis-diamminedichloroplatinum(II) resistance: a review.

Authors:  H Timmer-Bosscha; N H Mulder; E G de Vries
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

7.  Modulation of cisplatin cytotoxicity by sulphasalazine.

Authors:  S Awasthi; R Sharma; S S Singhal; N K Herzog; M Chaubey; Y C Awasthi
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

8.  Combination therapy with cisplatin and nifedipine induces apoptosis in cisplatin-sensitive and cisplatin-resistant human glioblastoma cells.

Authors:  S Kondo; D Yin; T Morimura; H Kubo; S Nakatsu; J Takeuchi
Journal:  Br J Cancer       Date:  1995-02       Impact factor: 7.640

9.  Factors affecting platinum concentrations in human surgical tumour specimens after cisplatin.

Authors:  D J Stewart; J M Molepo; R M Green; V A Montpetit; H Hugenholtz; A Lamothe; N Z Mikhael; M D Redmond; M Gadia; R Goel
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.